TCL Archive NCI Planning To Switch Drug Development Emphasis From Compound To Human Cancer Oriented Strategy October 26, 1984
TCL Archive In Brief: Calabresi Named To President’s Cancer Panel; Mays Leaves NCI Technology Office For IVAX May 5, 1995
TCL Archive In Brief: Hew Approves Patent Request From U. Arizona; Califano Still Pondering Bioassay Program Fate September 1, 1978